Bayview Pharmacy is pleased to present our compounded formulation of Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules. This unique formulation is specifically designed to address a range of allergic and respiratory conditions, such as Allergic Rhinitis, Common Cold, Sinusitis, Hay Fever, and Bronchitis. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period of time.

This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile. The combination of Chlorpheniramine Maleate and Phenylephrine HCl in our formulation works synergistically to reduce inflammation, alleviate congestion, and provide relief from the symptoms associated with these conditions.

If you have any questions about this formulation or how it can help manage your condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most effective treatment options tailored to your specific needs.

Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.

These capsules may interact with other medications, including those used to treat Allergic Rhinitis, Common Cold, Sinusitis, Hay Fever, and Bronchitis. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements.

Patients should also be aware of potential drug interactions with other medications, such as monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and other antihistamines. Interactions with alcohol should also be noted, as this may increase the risk of side effects.

Furthermore, potential interactions with other drugs that may affect the central nervous system, such as sedatives, hypnotics, and narcotics, should be considered. Additionally, potential interactions with other drugs that may affect the cardiovascular system, such as beta-blockers, calcium channel blockers, and diuretics, should be taken into account.

If you have any questions about potential interactions with Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules, please consult with your healthcare provider.

Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules are a compounded formulation designed to provide extended relief from symptoms associated with Allergic Rhinitis, Common Cold, Sinusitis, Hay Fever, and Bronchitis. This unique formulation combines the antihistamine properties of Chlorpheniramine Maleate, which works by blocking the action of histamine, and the decongestant properties of Phenylephrine HCl, which works by narrowing the blood vessels in the nasal passages. The result is a reduction in congestion, swelling, and other allergic symptoms.

The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This allows for a gradual release of the active ingredients over an extended period of time, offering sustained therapeutic effects and reduced dosing frequency. This slow release formulation provides relief from symptoms for up to 12 hours, improving patient compliance for medications requiring a controlled and prolonged release profile.

When taking Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules, it is crucial to adhere to the directions provided by your healthcare provider. The recommended dose is one capsule every 12 hours, which can be taken with or without food. It is advised not to exceed two capsules in a 24-hour period and not to continue the medication for more than 7 days unless directed by your healthcare provider.

Common side effects of Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules may include drowsiness, dry mouth, headache, and nausea. If you experience any of these side effects, it is important to contact your healthcare provider immediately.

If you have any questions or concerns about Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist for further information and guidance.

This compounded formulation of Chlorpheniramine Maleate 9 mg/Phenylephrine HCl 21 mg Slow Release Capsules, formulated with Methocel E4M, is designed to gradually release the encapsulated medication over an extended period of time. This controlled-release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, making it an ideal choice for medications requiring a controlled and prolonged release profile.

While primarily used for its antihistaminic and decongestant properties, this formulation may also be employed to treat a variety of other conditions. These include allergic conjunctivitis, urticaria, and pruritus, where it can help alleviate symptoms such as itching, redness, and swelling. It may also be used as a pre-operative medication to reduce the risk of anaphylaxis during surgery.

Furthermore, this formulation can be beneficial in managing the symptoms of motion sickness, such as nausea and vomiting, and vertigo, including dizziness and lightheadedness. It can also help reduce the symptoms of allergic reactions, such as itching, sneezing, and a runny nose.

If you have any questions about the use of this formulation for any of these conditions, or if you require further information, please do not hesitate to reach out. We are here to assist you in understanding the potential applications and benefits of this compounded formulation.